• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶受体表达涉及磷酸甘油酸激酶的酪氨酸磷酸化。

Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.

机构信息

Texas Lung Injury Institute, Department of Specialty Care Services, The University of Texas Health Science Center at Tyler, 11937 US HWY 271, Lab C-6, Tyler, TX 75708, USA.

出版信息

Mol Cell Biochem. 2010 Feb;335(1-2):235-47. doi: 10.1007/s11010-009-0273-4. Epub 2009 Sep 26.

DOI:10.1007/s11010-009-0273-4
PMID:19784757
Abstract

The interaction of urokinase-type plasminogen activator (uPA) with its receptor, uPAR, plays a central role in several pathophysiological processes, including cancer. uPA induces its own cell surface receptor expression through stabilization of uPAR mRNA. The mechanism involves binding of a 51 nt uPAR mRNA coding sequence with phosphoglycerate kinase (PGK) to down regulate cell surface uPAR expression. Tyrosine phosphorylation of PGK mediated by uPA treatment enhances uPAR mRNA stabilization. In contrast, inhibition of tyrosine phosphorylation augments PGK binding to uPAR mRNA and attenuates uPA-induced uPAR expression. Mapping the specific peptide region of PGK indicated that its first quarter (amino acids 1-100) interacts with uPAR mRNA. To determine if uPAR expression by uPA is regulated through activation of tyrosine residues of PGK, we mutated the specific tyrosine residue and tested mutant PGK for its ability to interfere with uPAR expression. Inhibition of tyrosine phosphorylation by mutating Y76 residue abolished uPAR expression induced by uPA treatment. These findings collectively demonstrate that Y76 residue present in the first quarter of the PGK molecule is involved in lung epithelial cell surface uPAR expression. This region can effectively mimic the function of a whole PGK molecule in inhibiting tumor cell growth.

摘要

尿激酶型纤溶酶原激活物(uPA)与其受体 uPAR 的相互作用在包括癌症在内的几种病理生理过程中起着核心作用。uPA 通过稳定 uPAR mRNA 来诱导其自身细胞表面受体表达。该机制涉及与磷酸甘油激酶(PGK)结合的 51nt uPAR mRNA 编码序列,以下调细胞表面 uPAR 表达。uPA 处理介导的 PGK 酪氨酸磷酸化增强了 uPAR mRNA 的稳定性。相比之下,抑制酪氨酸磷酸化增强了 PGK 与 uPAR mRNA 的结合,并减弱了 uPA 诱导的 uPAR 表达。PGK 的特定肽区的作图表明,其四分之一(氨基酸 1-100)与 uPAR mRNA 相互作用。为了确定 uPA 是否通过激活 PGK 的酪氨酸残基来调节 uPAR 的表达,我们突变了特定的酪氨酸残基,并测试了突变的 PGK 对 uPAR 表达的干扰能力。通过突变 Y76 残基抑制酪氨酸磷酸化,消除了 uPA 处理诱导的 uPAR 表达。这些发现共同表明,PGK 分子的四分之一中存在的 Y76 残基参与了肺上皮细胞表面 uPAR 的表达。该区域可以有效地模拟整个 PGK 分子在抑制肿瘤细胞生长中的功能。

相似文献

1
Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.尿激酶受体表达涉及磷酸甘油酸激酶的酪氨酸磷酸化。
Mol Cell Biochem. 2010 Feb;335(1-2):235-47. doi: 10.1007/s11010-009-0273-4. Epub 2009 Sep 26.
2
Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.脂多糖诱导的急性肺损伤中尿激酶型纤溶酶原激活物受体表达的转录后调控
Am J Respir Crit Care Med. 2009 Feb 15;179(4):288-98. doi: 10.1164/rccm.200712-1787OC. Epub 2008 Nov 21.
3
Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity.磷酸甘油酸激酶对尿激酶受体表达的调控与其催化活性无关。
Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L591-8. doi: 10.1152/ajplung.00319.2004. Epub 2005 Jun 10.
4
Regulation of urokinase receptor expression by protein tyrosine phosphatases.蛋白酪氨酸磷酸酶对尿激酶受体表达的调控
Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L414-21. doi: 10.1152/ajplung.00121.2006. Epub 2006 Oct 6.
5
Regulation of urokinase receptor expression by phosphoglycerate kinase.磷酸甘油酸激酶对尿激酶受体表达的调控
Am J Respir Cell Mol Biol. 2004 Jul;31(1):100-6. doi: 10.1165/rcmb.2003-0104OC. Epub 2004 Feb 5.
6
Posttranscriptional regulation of urokinase receptor expression by heterogeneous nuclear ribonuclear protein C.异质性细胞核核糖核蛋白C对尿激酶受体表达的转录后调控
Biochemistry. 2008 Jun 17;47(24):6508-17. doi: 10.1021/bi702338y. Epub 2008 May 22.
7
Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells.尿激酶受体信使核糖核酸稳定性涉及肺上皮细胞中的酪氨酸磷酸化。
Am J Respir Cell Mol Biol. 2004 Jan;30(1):69-75. doi: 10.1165/rcmb.2002-0305OC. Epub 2003 Jun 19.
8
Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.人尿激酶型纤溶酶原激活剂与其受体的结合:涉及物种特异性和结合的残基。
Arterioscler Thromb Vasc Biol. 1998 May;18(5):693-701. doi: 10.1161/01.atv.18.5.693.
9
The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.尿激酶型纤溶酶原激活物受体介导培养的内皮细胞中粘着斑蛋白的酪氨酸磷酸化和丝裂原活化蛋白激酶的激活。
J Biol Chem. 1998 Jul 17;273(29):18268-72. doi: 10.1074/jbc.273.29.18268.
10
A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.神经元型尿激酶型纤溶酶原激活剂(uPA)与星形胶质细胞型uPA受体(uPAR)之间的相互作用促进缺血性脑内星形胶质细胞激活和突触恢复。
J Neurosci. 2017 Oct 25;37(43):10310-10322. doi: 10.1523/JNEUROSCI.1630-17.2017. Epub 2017 Sep 20.

引用本文的文献

1
Molecular characterization and analysis of the drug resistance-associated protein phosphoglycerate kinase of ..的耐药相关蛋白磷酸甘油酸激酶的分子特征及分析
Parasitology. 2024 Oct;151(12):1371-1379. doi: 10.1017/S0031182024001355. Epub 2024 Oct 18.
2
The Warburg Effect and lactate signaling augment Fgf-MAPK to promote sensory-neural development in the otic vesicle.沃伯格效应和乳酸信号增强 Fgf-MAPK 促进耳泡感觉神经发育。
Elife. 2020 Apr 27;9:e56301. doi: 10.7554/eLife.56301.
3
Understanding protein multifunctionality: from short linear motifs to cellular functions.

本文引用的文献

1
Regulation of urokinase receptor expression by protein tyrosine phosphatases.蛋白酪氨酸磷酸酶对尿激酶受体表达的调控
Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L414-21. doi: 10.1152/ajplung.00121.2006. Epub 2006 Oct 6.
2
Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.肺上皮细胞中hnRNP C对尿激酶受体mRNA稳定性的调控
Mol Cell Biochem. 2005 Apr;272(1-2):107-18. doi: 10.1007/s11010-005-7644-2.
3
Regulation of urokinase receptor expression by phosphoglycerate kinase is independent of its catalytic activity.
理解蛋白质多功能性:从短线性基序到细胞功能。
Cell Mol Life Sci. 2019 Nov;76(22):4407-4412. doi: 10.1007/s00018-019-03273-4. Epub 2019 Aug 20.
4
The impact of COX-2 on invasion of osteosarcoma cell and its mechanism of regulation.COX-2 对骨肉瘤细胞侵袭的影响及其调控机制。
Cancer Cell Int. 2014 Mar 25;14:27. doi: 10.1186/1475-2867-14-27. eCollection 2014.
磷酸甘油酸激酶对尿激酶受体表达的调控与其催化活性无关。
Am J Physiol Lung Cell Mol Physiol. 2005 Oct;289(4):L591-8. doi: 10.1152/ajplung.00319.2004. Epub 2005 Jun 10.
4
Urokinase signal transduction and its role in cell migration.尿激酶信号转导及其在细胞迁移中的作用。
FASEB J. 2005 Feb;19(2):195-202. doi: 10.1096/fj.04-1644com.
5
Regulation of urokinase receptor expression by phosphoglycerate kinase.磷酸甘油酸激酶对尿激酶受体表达的调控
Am J Respir Cell Mol Biol. 2004 Jul;31(1):100-6. doi: 10.1165/rcmb.2003-0104OC. Epub 2004 Feb 5.
6
Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.HuR对尿激酶和尿激酶受体mRNA的稳定作用与其由活化的丝裂原活化蛋白激酶激活的蛋白激酶2诱导的细胞质积累有关。
Mol Cell Biol. 2003 Oct;23(20):7177-88. doi: 10.1128/MCB.23.20.7177-7188.2003.
7
Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells.尿激酶受体信使核糖核酸稳定性涉及肺上皮细胞中的酪氨酸磷酸化。
Am J Respir Cell Mol Biol. 2004 Jan;30(1):69-75. doi: 10.1165/rcmb.2002-0305OC. Epub 2003 Jun 19.
8
Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.尿激酶介导的非小细胞肺癌中尿激酶受体表达的转录后调控
Int J Cancer. 2003 Jun 20;105(3):353-60. doi: 10.1002/ijc.11091.
9
Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.Rac1-MKK3-p38-MAPKAPK2信号通路促进侵袭性乳腺癌细胞中尿激酶型纤溶酶原激活剂mRNA的稳定性。
J Biol Chem. 2002 Dec 13;277(50):48379-85. doi: 10.1074/jbc.M209542200. Epub 2002 Oct 10.
10
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.尿激酶型纤溶酶原激活剂通过转录后机制上调其细胞受体的表达。
FEBS Lett. 2001 Nov 23;508(3):379-84. doi: 10.1016/s0014-5793(01)03104-0.